Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05882_nanopub.RA1-pz8N_MAghftnb3on5QiDLPYQ27PPKEVcN83JhJh_8#assertion>. }
Showing items 1 to 13 of
13
with 100 items per page.
- drugbank:DB05882 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05882 label "CHF 4227 [drugbank:DB05882]" assertion.
- drugbank:DB05882 seeAlso DB05882 assertion.
- drugbank:DB05882 description "CHF 4227 is a new selective estrogen receptor modulator (SERM). The compound has a high receptor affinity and has shown promising efficacy in the prevention of bone loss in animal models of osteoporosis. Additionally, the compound has shown no uterotrophic activity suggesting a potential therapeutic advantage over drugs normally used in postmenopausal therapy." assertion.
- drugbank:DB05882 identifier "drugbank:DB05882" assertion.
- drugbank:DB05882 title "CHF 4227" assertion.
- drugbank:DB05882 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05882 drugbank_vocabulary:drugbank-id "DB05882" assertion.
- drugbank:DB05882 bio2rdf_vocabulary:x-identifiers.org DB05882 assertion.
- drugbank:DB05882 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05882" assertion.
- drugbank:DB05882 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05882 bio2rdf_vocabulary:identifier "DB05882" assertion.
- drugbank:DB05882 drugbank_vocabulary:x-wikipedia wikipedia:Selective_estrogen_receptor_modulator assertion.